50-198-6135
EBV LMP2 Rabbit anti-Human, Polyclonal, Bioss
Manufacturer: Bioss
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 50-198-6135-Each-of-1 | In Stock | ₹ 36,897.75 |
50-198-6135 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 36,897.75
GST (18%): ₹ 6,641.595
Total Price: ₹ 43,539.345
Antigen
EBV LMP2
Classification
Polyclonal
Conjugate
Unconjugated
Host Species
Rabbit
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Human
Product Type
Antibody
Isotype
IgG
Applications
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration
1 μg/mL
Formulation
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen
KLH conjugated synthetic peptide derived from HHV4t2 LMP2.
Quantity
100 μL
Primary or Secondary
Primary
Content And Storage
-20°C
Form
Liquid
Related Products
Description
- Epstein Barr virus (EBV) is a member of the herpesvirus family and one of the most common human viruses
- Most people become infected with EBV during their lives
- Primary infections usually results in infectious mononucleosis (glandular fever) but the virus can also lay dormant in B lymphocytes and when reactivated become associated with more serious disease such as Burkitt′s lymphoma, nasopharyngeal carcinoma and Hodgkin′s disease
- EBV latently infects B lymphocytes
- Infected B cells express EBV nuclear antigens and latent proteins LMP1, LMP2A and LMP2B
- LMP2A forms aggregates in the plasma membranes of B lymphocytes, where it functions as a negative regulator of the Src and Syk protein tyrosine kinases
- Studies show that LMP2A blocks B-cell receptor (BCR) signal transduction in EBV immortalized B cells in vitro and may play an important role in maintaining a latent EBV infection within the peripheral blood B cells of infected individuals.
Compare Similar Items
Show Difference
Antigen: EBV LMP2
Classification: Polyclonal
Conjugate: Unconjugated
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Human
Product Type: Antibody
Isotype: IgG
Applications: Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen: KLH conjugated synthetic peptide derived from HHV4t2 LMP2.
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
EBV LMP2
Classification:
Polyclonal
Conjugate:
Unconjugated
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Applications:
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen:
KLH conjugated synthetic peptide derived from HHV4t2 LMP2.
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid
Antigen: MLCK
Classification: Polyclonal
Conjugate: Unconjugated
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Human
Product Type: Antibody
Isotype: IgG
Applications: Immunofluorescence, Immunohistochemistry (Paraffin)
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen: KLH conjugated synthetic peptide derived from human MLCK.
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
MLCK
Classification:
Polyclonal
Conjugate:
Unconjugated
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Applications:
Immunofluorescence, Immunohistochemistry (Paraffin)
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen:
KLH conjugated synthetic peptide derived from human MLCK.
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid
Antigen: AFP
Classification: Polyclonal
Conjugate: Unconjugated
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Human
Product Type: Antibody
Isotype: IgG
Applications: Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen: KLH conjugated synthetic peptide derived from human AFP.
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
AFP
Classification:
Polyclonal
Conjugate:
Unconjugated
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Applications:
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen:
KLH conjugated synthetic peptide derived from human AFP.
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid
Antigen: SLCO2A1
Classification: Polyclonal
Conjugate: Unconjugated
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Human
Product Type: Antibody
Isotype: IgG
Applications: Flow Cytometry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen: KLH conjugated synthetic peptide derived from human PGT/Slco2a1.
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
SLCO2A1
Classification:
Polyclonal
Conjugate:
Unconjugated
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Applications:
Flow Cytometry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen:
KLH conjugated synthetic peptide derived from human PGT/Slco2a1.
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid